Advisory Services Network’s Decoy Therapeutics DCOY Stock Holding History

Advisory Services Network’s Portfolio DCOY Stock Details DCOY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-41	Closed	-$268	–	4256
2026 Q1	$268	Buy	+41	New	+$353	﹤0.01%	4520
2025 Q4	–	Sell	-42	Closed	-$1.83K	–	3879
2025 Q3	$1.83K	Buy	+42	New	+$3.87K	﹤0.01%	3818

Other funds holding DCOY

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Advisory Services Network's DCOY Position: Q2 2026 in Review

Advisory Services Network sold out of Decoy Therapeutics (DCOY) in Q2 2026, closing a stake of 41 shares — an estimated $268 sold.

Advisory Services Network first reported a position in DCOY in Q3 2025 and held it in 2 quarters. The position peaked at $1.83K in Q3 2025. 4 funds tracked by Wall St. Rank hold DCOY as of Q2 2026.

Advisory Services Network reported no remaining Decoy Therapeutics position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 41 Decoy Therapeutics shares in Q2 2026, an estimated $268.
Advisory Services Network first reported a position in Decoy Therapeutics in Q3 2025 and held it in 2 quarters.
Advisory Services Network's Decoy Therapeutics position peaked at $1.83K in Q3 2025.
4 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.